# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Roald Amundsen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX003-SYN
- Date: 2026-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ingrid Solheim-Achebe, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Twelve-week review of finger pain on duloxetine. **S**

## History of present illness

Mr. Amundsen returns six weeks after starting duloxetine; he has taken 60 mg daily for five weeks. The mild nausea of the first days has gone, and he has had no drowsiness, dizziness or sweating. His average finger pain over the past week is 3 of 10; the cold attacks are shorter and less frequent, though the spring weather is milder too. He sleeps through most nights. He uses capsaicin cream only on cold days. He can manage buttons and keys outdoors with liner gloves. He did not have the blood test that was meant to be done two to four weeks after starting duloxetine. **S**

| Element | Detail |
|---|---|
| Finger pain | Average 3 of 10 over the past week |
| Medicine effects | Early nausea gone; no drowsiness, dizziness or sweating |
| Sleep | Sleeping through most nights |
| Function | Manages buttons and keys outdoors with liner gloves |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Finger burning in the cold, much less; no dizziness |
| Gastrointestinal | Negative | No nausea now; normal appetite |
| Psychiatric | Negative | Mood better; PHQ-9 3 |

3 systems reviewed. **S**

## Current medications

- Capsaicin 0.075% cream, a small amount rubbed into the painful fingers four times a day; wash hands after use and keep away from the eyes **S**
- Duloxetine 60 mg delayed-release capsule, one capsule by mouth daily; do not stop suddenly **S**

## Allergies

- No known allergy **S**

## Objective

BP 132/82 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 78.6 kg; BMI 23.5 kg/m². All vital signs are synthetic.

Finger pain, 0 to 10: 3; PHQ-9: 3; Sodium: 139 mmol/L; ALT: 27 U/L. All results are synthetic.

## Change since baseline

- Finger pain, 0 to 10: 6 at baseline, 3 at this visit **S**
- PHQ-9: 5 at baseline, 3 at this visit **S**
- Sodium: 141 mmol/L at baseline, 139 mmol/L at this visit **S**
- ALT: 24 U/L at baseline, 27 U/L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 132/82, pulse 66, weight 78.6 kg |
| Hands | Fingertips cool; skin intact |
| Neurological | Alert; no tremor |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-frostbite neuropathic pain of the fingers, improving on duloxetine** (M79.2). Average pain down to 3 of 10 and sleep better on duloxetine 60 mg, without drowsiness; part of the improvement may be the milder weather. Sodium 139 mmol/L and ALT 27 U/L, both normal. Blood pressure 132/82, a little above his earlier readings, which duloxetine can do; to be rechecked. PHQ-9 3. **S**
   - Continue duloxetine 60 mg daily and capsaicin cream as needed.
   - Recheck blood pressure at the next visit.
   - Review in about five weeks.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pain severity (0 to 10 numeric rating) and overall improvement | Every review, and early after starting or changing a medicine | Completed today | Average 3 of 10, from 6 at intake |
| Medication safety | Adverse effects, especially drowsiness, dizziness and nausea | Every review, and early after starting or changing a medicine | Completed today | Early nausea only; no drowsiness or dizziness |
| Examination | Daily activities and participation: fine hand tasks in the cold, driving, flying | Every review, and early after starting or changing a medicine | Completed today | Manages fine tasks outdoors with gloves; driving |
| Survey | Mood (PHQ-9) and anxiety | Every review, and early after starting or changing a medicine | Completed today | PHQ-9 3 |
| Examination | Sleep quality | Every review, and early after starting or changing a medicine | Completed today | Sleeping through most nights |
| Examination | Blood pressure | Before starting duloxetine and periodically on it | Completed today | 132/82 mmHg, up from 126/78 before duloxetine; recheck at the next visit |
| Laboratory | Sodium and liver enzyme (ALT) on duloxetine | Baseline, then once in the first weeks of treatment | Completed today | Sodium 139 mmol/L and ALT 27 U/L. Protocol deviation: the test ordered for two to four weeks after starting duloxetine was not drawn, because no date was booked and it was missed at the preventive visit; it was drawn today, six weeks after starting. No harm resulted: both results are normal. Corrective action: book the blood test with a date when a medicine needing monitoring is started |
| Medication safety | Interactions: no tramadol or other serotonergic drugs; caution with oral NSAIDs; alcohol | Every review | Completed today | No new medicines; rare alcohol |
| Self-management | Skin of the fingers and cold protection | Every review, and early after starting or changing a medicine | Completed today | Skin intact |

## Goal progress

- Average finger pain at or below 3 of 10, with fewer cold attacks, by four months. In progress; target 2026-06-09. **S**
- Able to handle buttons, keys and a pen outdoors in the cold with protective gloves. Outcome by 2026-05-05: Managing with liner and heated gloves and hand warmers. **S**
- Any medicine used causes no daytime drowsiness that affects driving or flying. In progress; target 2026-06-09. **S**

## Guideline basis

- Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020), National Institute for Health and Care Excellence
- Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024), Wilderness Medical Society

## Follow-up

- Review in about five weeks, with a blood pressure check. **S**
- Next scheduled visit 2026-06-09: seventeen-week review: finger pain, the ankle sprain, and the risks of an Arctic air search flight. **S**
